7Baggers

UBER Stock Cash Flow Statements

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
     Operating Cash Flow  
     Investing Cash Flow  
     Financing Cash Flow  
     Net Income  
    Quarterly
     | 
    Annual
     
    20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 -2,416-1,060.14295.711,651.573,007.434,363.295,719.147,075Milllion
    Quarterly Cash Flow Statements
    Quarterly
     | 
    Annual
     
      Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
                             
        cash flows from operating activities                     
        net income including non-controlling interests-663,000,000 1,700,000,000 219,000,000 394,000,000 -157,000,000 600,000,000 -1,204,000,000 -2,616,000,000 -5,918,000,000 879,000,000 -2,439,000,000 1,112,000,000 -122,000,000 -962,000,000 -1,108,000,000 -1,772,000,000 -2,946,000,000 -1,091,000,000    
        adjustments to reconcile net income to net cash from operating activities:                     
        depreciation and amortization194,000,000 203,000,000 205,000,000 208,000,000 207,000,000 223,000,000 227,000,000 243,000,000 254,000,000 246,000,000 218,000,000 226,000,000 212,000,000 180,000,000 138,000,000 129,000,000 128,000,000 101,000,000 102,000,000 123,000,000 146,000,000 
        bad debt expense26,000,000 29,000,000 19,000,000 24,000,000 20,000,000 38,000,000 25,000,000 33,000,000 18,000,000 34,000,000 26,000,000 26,000,000 23,000,000 25,000,000 19,000,000 10,000,000 22,000,000 13,000,000 12,000,000 20,000,000 47,000,000 
        stock-based compensation484,000,000 469,000,000 492,000,000 504,000,000 470,000,000 482,000,000 482,000,000 470,000,000 359,000,000 334,000,000 281,000,000 272,000,000 281,000,000 236,000,000 183,000,000 131,000,000 277,000,000 243,000,000 401,000,000 3,941,000,000 11,000,000 
        deferred income taxes-16,000,000 -6,000,000 16,000,000 6,000,000 10,000,000 -190,000,000 16,000,000 14,000,000 -281,000,000 -210,000,000 -115,000,000 -487,000,000 120,000,000 6,000,000 10,000,000       
        loss (income) from equity method investments4,000,000     -42,000,000 -30,000,000 -17,000,000 -18,000,000             
        unrealized (gain) loss on debt and equity securities721,000,000 -1,000,000,000 96,000,000 -386,000,000 -320,000,000   1,677,000,000 5,570,000,000   -1,912,000,000 -63,000,000 2,000,000 7,000,000 2,000,000 114,000,000     
        impairments of goodwill, long-lived assets and other assets 9,000,000 -1,000,000 11,000,000 67,000,000 13,000,000 0 2,000,000 13,000,000 100,000,000 0 0 16,000,000 32,000,000 75,000,000 104,000,000 193,000,000     
        unrealized foreign currency transactions150,000,000 -18,000,000 71,000,000 2,000,000 83,000,000 71,000,000 15,000,000 25,000,000 -15,000,000 26,000,000 14,000,000 -15,000,000 13,000,000 4,000,000 31,000,000 6,000,000 7,000,000 32,000,000 -11,000,000 -1,000,000 -4,000,000 
        other-59,000,000 -23,000,000 -35,000,000 6,000,000 4,000,000 -12,000,000 7,000,000 -7,000,000 5,000,000 -46,000,000 -12,000,000 -3,000,000 65,000,000 -4,000,000 -34,000,000 5,000,000 -10,000,000 5,000,000 19,000,000 0 -1,000,000 
        change in assets and liabilities, net of impact of business acquisitions and disposals:                     
        accounts receivable-422,000,000 -395,000,000 -518,000,000 -13,000,000 168,000,000 -323,000,000 -90,000,000 -103,000,000 -26,000,000 -243,000,000 -205,000,000 -114,000,000 -35,000,000 -238,000,000 -137,000,000 73,000,000 444,000,000 -65,000,000 94,000,000 -226,000,000 -210,000,000 
        prepaid expenses and other assets-322,000,000 -281,000,000 -948,000,000 -114,000,000 -119,000,000 -139,000,000 -115,000,000 78,000,000 -20,000,000 -7,000,000 -220,000,000 58,000,000 -67,000,000 -65,000,000 18,000,000 112,000,000 29,000,000 -11,000,000 -289,000,000 -103,000,000 -75,000,000 
        operating lease right-of-use assets46,000,000 50,000,000 47,000,000 42,000,000 52,000,000 51,000,000 47,000,000 53,000,000 42,000,000 49,000,000 39,000,000 39,000,000 38,000,000 67,000,000 137,000,000 80,000,000 57,000,000 66,000,000    
        accounts payable46,000,000 -22,000,000 112,000,000 -19,000,000 -7,000,000 -53,000,000 -35,000,000 -53,000,000 8,000,000 19,000,000 -114,000,000 188,000,000 -3,000,000 -99,000,000 -24,000,000 36,000,000 -46,000,000 118,000,000 -32,000,000   
        accrued insurance reserves693,000,000 576,000,000 501,000,000 588,000,000 350,000,000 251,000,000 159,000,000 192,000,000 134,000,000 26,000,000 469,000,000 48,000,000 -27,000,000 13,000,000 -8,000,000 -85,000,000 77,000,000     
        accrued expenses and other liabilities590,000,000 -216,000,000 740,000,000 -87,000,000 -142,000,000 -405,000,000 483,000,000 486,000,000 -72,000,000 177,000,000 129,000,000 206,000,000 556,000,000 6,000,000 414,000,000 -17,000,000 -320,000,000 -37,000,000 -143,000,000 796,000,000 344,000,000 
        operating lease liabilities-56,000,000 -43,000,000 -47,000,000 -46,000,000 -44,000,000 -46,000,000 -81,000,000 -49,000,000 -39,000,000 -60,000,000 -54,000,000 -20,000,000 -50,000,000 -27,000,000 -62,000,000 7,000,000 -49,000,000 -59,000,000    
        net cash from operating activities1,416,000,000 823,000,000 966,000,000 1,190,000,000 606,000,000 -244,000,000 432,000,000 439,000,000 15,000,000 -107,000,000 614,000,000 -341,000,000 -611,000,000 -805,000,000 -406,000,000 -1,071,000,000 -463,000,000 -1,799,000,000 -878,000,000 -922,000,000 -722,000,000 
        cash flows from investing activities                     
        purchases of property and equipment-57,000,000 -55,000,000 -61,000,000 -50,000,000 -57,000,000 -59,000,000 -74,000,000 -57,000,000 -62,000,000 -80,000,000 -90,000,000 -57,000,000 -71,000,000 -123,000,000 -131,000,000 -164,000,000 -198,000,000     
        purchases of non-marketable equity securities-174,000,000 -10,000,000    0 0 -1,000,000 -13,000,000 -125,000,000 0 -54,000,000 -803,000,000         
        purchases of marketable securities-2,029,000,000 -2,844,000,000 -3,723,000,000 -1,361,000,000 -846,000,000     0 -587,000,000 -190,000,000 -336,000,000 -608,000,000 -481,000,000 -519,000,000 -493,000,000     
        proceeds from maturities and sales of marketable securities2,030,000,000 2,076,000,000 1,366,000,000 1,127,000,000 500,000,000 0    0 1,148,000,000 447,000,000 696,000,000 559,000,000 379,000,000 322,000,000 100,000,000     
        proceeds from sale of equity method investment9,000,000  18,000,000                   
        other investing activities-21,000,000 14,000,000 26,000,000 -11,000,000 4,000,000 -2,000,000 -7,000,000 4,000,000 -1,000,000 -5,000,000 0 9,000,000 8,000,000 14,000,000 57,000,000 -10,000,000 -1,000,000     
        net cash from investing activities-242,000,000 -819,000,000 -2,416,000,000 408,000,000 -399,000,000 -1,769,000,000 321,000,000 -54,000,000 -135,000,000 -2,268,000,000 1,216,000,000 101,000,000 -250,000,000 -192,000,000 -365,000,000 -456,000,000 -1,856,000,000 -711,000,000 -129,000,000 -154,000,000 204,000,000 
        cash flows from financing activities                     
        issuance of term loans and notes, net of issuance costs  0 0 1,121,000,000                 
        principal repayment on term loan and notes-6,000,000 -1,525,000,000 -6,000,000 -7,000,000 -1,137,000,000                 
        principal payments on finance leases-42,000,000 -53,000,000 -36,000,000 -42,000,000 -40,000,000 -37,000,000 -39,000,000 -46,000,000 -62,000,000 -60,000,000 -58,000,000 -61,000,000 -47,000,000  -56,000,000 -59,000,000 -60,000,000     
        other financing activities-52,000,000 17,000,000 -9,000,000 6,000,000 -51,000,000 -5,000,000 -4,000,000 -8,000,000 -51,000,000 51,000,000 5,000,000 30,000,000 15,000,000 48,000,000 -1,000,000 -6,000,000 -3,000,000     
        net cash from financing activities-100,000,000 46,000,000 -76,000,000 42,000,000 -107,000,000 -89,000,000 212,000,000 5,000,000 -113,000,000 414,000,000 1,556,000,000 36,000,000 -226,000,000 896,000,000 428,000,000 118,000,000 -63,000,000 -83,000,000 1,993,000,000 7,075,000,000 -46,000,000 
        effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents-94,000,000 89,000,000 -69,000,000 27,000,000 16,000,000 145,000,000 -195,000,000 -118,000,000 20,000,000 -24,000,000 -50,000,000 51,000,000 -46,000,000 75,000,000 8,000,000 -19,000,000 -156,000,000 19,000,000 -35,000,000 9,000,000 3,000,000 
        net increase in cash and cash equivalents, and restricted cash and cash equivalents980,000,000 139,000,000   116,000,000 -1,957,000,000 770,000,000   -1,985,000,000    -26,000,000 -335,000,000   -2,574,000,000 951,000,000 6,008,000,000 -561,000,000 
        cash and cash equivalents, and restricted cash and cash equivalents                     
        beginning of period7,004,000,000 0   6,677,000,000 0 0   0 0   0 0 0 12,067,000,000 0 0 0 8,209,000,000 
        end of period7,984,000,000      770,000,000    3,336,000,000           
        income from sale of investments                     
        gain on business divestitures     0    0 0 0 -1,684,000,000 -77,000,000 0       
        impairment of equity method investment     0 0 0 182,000,000             
        revaluation of mlu b.v. call option     -11,000,000 -10,000,000 11,000,000 -181,000,000             
        collateral held by insurer         0 724,000,000 28,000,000 108,000,000 80,000,000 81,000,000 86,000,000 92,000,000     
        proceeds from sale of non-marketable equity securities         0 0 0 500,000,000         
        proceeds from sale of equity method investments                     
        proceeds from business divestiture                     
        acquisition of businesses, net of cash acquired     0 0 0 -59,000,000 -2,203,000,000 -31,000,000 -52,000,000 -28,000,000 65,000,000    0 0   
        purchase of notes receivables                     
        proceeds from issuance and sale of subsidiary stock units     0                
        proceeds from the issuance of common stock under the employee stock purchase plan 45,000,000 0   33,000,000 0   40,000,000 0   43,000,000 0       
        issuance of term loan and notes, net of issuance costs                     
        purchase of capped calls                     
        uber technologies, inc.                     
        consolidated statements of cash flows                     
        principal repayment on careem notes         -112,000,000 -1,000,000 0 -194,000,000 0 0       
        supplemental disclosures of cash flow information                     
        cash paid for:                     
        interest, net of amount capitalized 160,000,000    123,000,000 137,000,000   130,000,000 103,000,000   116,000,000 85,000,000 120,000,000 91,000,000 119,000,000 47,000,000 124,000,000 42,000,000 
        income taxes, net of refunds 64,000,000    26,000,000 44,000,000   16,000,000 20,000,000   14,000,000 10,000,000 22,000,000 36,000,000 28,000,000 25,000,000 46,000,000 34,000,000 
        non-cash investing and financing activities:                     
        finance lease obligations 13,000,000    173,000,000 95,000,000   69,000,000 32,000,000    59,000,000       
        right-of-use assets obtained in exchange for lease obligations 37,000,000    101,000,000 -17,000,000               
        common stock issued in connection with acquisitions         901,000,000    3,802,000,000        
        ownership interest received in exchange for divestitures         0            
        conversion of convertible notes to common stock related to careem                     
        income from equity method investments  -3,000,000 -4,000,000 -36,000,000     9,000,000 13,000,000 7,000,000 8,000,000 7,000,000 8,000,000       
        income from sale of investment  0                   
        principal repayments on careem notes                     
        reconciliation of cash and cash equivalents, and restricted cash and cash equivalents to the condensed consolidated balance sheets                     
        cash and cash equivalents      468,000,000    2,039,000,000    -600,000,000 -1,411,000,000 8,165,000,000  906,000,000 5,999,000,000 5,745,000,000 
        restricted cash and cash equivalents-current      67,000,000    90,000,000    95,000,000 -70,000,000 193,000,000  -104,000,000 1,000,000 136,000,000 
        restricted cash and cash equivalents-non-current      235,000,000    1,207,000,000    170,000,000 53,000,000 1,171,000,000  149,000,000 8,000,000 1,801,000,000 
        total cash and cash equivalents, and restricted cash and cash equivalents      770,000,000    3,336,000,000    -335,000,000 -1,428,000,000 9,529,000,000  951,000,000 6,008,000,000 7,682,000,000 
        gain from sale of investments         -242,000,000            
        proceeds from sale of equity method investments and grant of related call option                     
        proceeds from business divestiture, net of cash divested                     
        issuance of careem notes including the holdback amount                     
        unrealized loss on debt and equity securities                     
        purchase of notes receivable                     
        reclassification from assets held for sale during the period          0           
        ownership interest received in exchange for divestiture                     
        conversion of convertible notes to common stock          0           
        gain on business divestiture                -154,000,000     
        taxes paid related to net share settlement of equity awards             -2,000,000    -59,000,000 -146,000,000   
        proceeds from issuance and sale of subsidiary preferred stock units                     
        proceeds from sale of subsidiary preferred stock units                     
        purchase of note receivable           -2,000,000 -216,000,000  0       
        ownership interest received in exchange for the divestitures                     
        gain on forfeiture of unvested warrants and related share repurchases                     
        purchases of equity method investments                     
        repurchase of stock subject to put options related to yandex                     
        issuance of unsecured convertible notes in connection with careem acquisition                     
        change in assets and liabilities, net of impact of business acquisition and disposals:                     
        impairment of long-lived assets held for sale                     
        purchase of intangible assets                     
        purchase of non-marketable debt securities                     
        purchase of non-marketable investments                     
        proceeds from issuance of common stock in private placement                     
        repurchase of outstanding shares                     
        proceeds from revolving lines of credit                     
        stock-based compensation capitalized as software development costs                     
        changes in share repurchase commitment made in each period                     
        deferred unpaid offering costs                     
        change in operating assets and liabilities, net of impact of business acquisitions and disposals:                     
        investments in debt securities                     
        gain on extinguishment of convertible notes and settlement of derivative                     
        changes in operating assets and liabilities: